简体中文
 

Talent recruitment

人才招聘

Pharmaceutical intermediates and international transfer, my country's growth exceeds the global average
Source: | Author:hkw5f7847 | Published time: 2020-07-25 | 1805 Views | Share:
      Pharmaceutical intermediates are chemical products in form, but are closely connected with medicines, providing main and auxiliary chemical substances for the synthesis of APIs. With lower costs and sufficient supply of chemical raw materials, my country has formed a strong intermediate production capacity. Currently, it has been able to produce more than 2,000 intermediates and the market size is close to 200 billion yuan.
      It is expected that under the background of industrial transfer, the growth of my country's pharmaceutical intermediates will exceed the global average, and the future industry growth rate will be more than 15%, while advanced pharmaceutical intermediates will grow even faster.
      The listed pharmaceutical intermediate companies involve multiple varieties of biological drugs, tumors, diabetes, antibiotics, etc. The corresponding products and application fields of the intermediates are different, but according to the business model, it can be simplified into customized and self-produced and self-sold models. Among them, the former competitiveness is reflected in research and development, customer base, management and production systems, and the latter is reflected in scale, cost and process control.
      In terms of specific companies, Tianma Jinghua and Yongtai Technology, which have large new production capacity, are recommended. Lianhua Technology, which has a good customer base and abundant product reserves, will continue to grow in the future after years of high growth.